These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8891723)

  • 121. Control of the G1/S transition.
    Reed SI
    Cancer Surv; 1997; 29():7-23. PubMed ID: 9338094
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Inactivation of cyclin-dependent kinase inhibitor genes and development of human acute leukemias.
    Ragione FD; Iolascon A
    Leuk Lymphoma; 1997 Mar; 25(1-2):23-35. PubMed ID: 9130611
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Histone acetylation and the cell-cycle in cancer.
    Wang C; Fu M; Mani S; Wadler S; Senderowicz AM; Pestell RG
    Front Biosci; 2001 Apr; 6():D610-29. PubMed ID: 11282573
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Cyclin-dependent kinase inhibitors in yeast, animals, and plants: a functional comparison.
    De Clercq A; Inzé D
    Crit Rev Biochem Mol Biol; 2006; 41(5):293-313. PubMed ID: 16911957
    [TBL] [Abstract][Full Text] [Related]  

  • 125. G1 control in mammalian cells.
    Reed SI; Bailly E; Dulic V; Hengst L; Resnitzky D; Slingerland J
    J Cell Sci Suppl; 1994; 18():69-73. PubMed ID: 7883795
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Mechanisms of TGF-beta-induced cell cycle arrest.
    Hocevar BA; Howe PH
    Miner Electrolyte Metab; 1998; 24(2-3):131-5. PubMed ID: 9525695
    [TBL] [Abstract][Full Text] [Related]  

  • 127. New Insights into CDK Regulators: Novel Opportunities for Cancer Therapy.
    Bury M; Le Calvé B; Ferbeyre G; Blank V; Lessard F
    Trends Cell Biol; 2021 May; 31(5):331-344. PubMed ID: 33676803
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Cyclins, Cyclin-Dependent Kinases, and Cyclin-Dependent Kinase Inhibitors in the Mouse Nervous System.
    Grison A; Atanasoski S
    Mol Neurobiol; 2020 Jul; 57(7):3206-3218. PubMed ID: 32506380
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy.
    Chou J; Quigley DA; Robinson TM; Feng FY; Ashworth A
    Cancer Discov; 2020 Mar; 10(3):351-370. PubMed ID: 32071145
    [TBL] [Abstract][Full Text] [Related]  

  • 130. p27Kip1 metabolism: a fascinating labyrinth.
    Borriello A; Cucciolla V; Oliva A; Zappia V; Della Ragione F
    Cell Cycle; 2007 May; 6(9):1053-61. PubMed ID: 17426451
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Cyclin-dependent kinases in breast cancer: expression pattern and therapeutic implications.
    Sofi S; Mehraj U; Qayoom H; Aisha S; Asdaq SMB; Almilaibary A; Mir MA
    Med Oncol; 2022 Apr; 39(6):106. PubMed ID: 35486263
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Interconnection between Metabolism and Cell Cycle in Cancer.
    Icard P; Fournel L; Wu Z; Alifano M; Lincet H
    Trends Biochem Sci; 2019 Jun; 44(6):490-501. PubMed ID: 30655165
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Heat shock effects on cell cycle progression.
    Kühl NM; Rensing L
    Cell Mol Life Sci; 2000 Mar; 57(3):450-63. PubMed ID: 10823246
    [TBL] [Abstract][Full Text] [Related]  

  • 134. An Unanticipated Modulation of Cyclin-Dependent Kinase Inhibitors: The Role of Long Non-Coding RNAs.
    Bencivenga D; Stampone E; Vastante A; Barahmeh M; Della Ragione F; Borriello A
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456025
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Targeting cell cycle regulators in hematologic malignancies.
    Aleem E; Arceci RJ
    Front Cell Dev Biol; 2015; 3():16. PubMed ID: 25914884
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Cyclin-dependent kinase inhibitors in brain cancer: current state and future directions.
    Juric V; Murphy B
    Cancer Drug Resist; 2020; 3(1):48-62. PubMed ID: 35582046
    [TBL] [Abstract][Full Text] [Related]  

  • 137. The SIAMESE family of cell-cycle inhibitors in the response of plants to environmental stresses.
    Braat J; Havaux M
    Front Plant Sci; 2024; 15():1362460. PubMed ID: 38434440
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Immunomodulatory Roles of Cell Cycle Regulators.
    Laphanuwat P; Jirawatnotai S
    Front Cell Dev Biol; 2019; 7():23. PubMed ID: 30863749
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Cyclin-Dependent Kinase Inhibitors in Hematological Malignancies-Current Understanding, (Pre-)Clinical Application and Promising Approaches.
    Richter A; Schoenwaelder N; Sender S; Junghanss C; Maletzki C
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34065376
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Cyclin-dependent kinase inhibitors (CKIs) and hematological malignancies.
    Baghdassarian N; Ffrench M
    Hematol Cell Ther; 1996 Aug; 38(4):313-23. PubMed ID: 8891723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.